| CCORT/CCS quality indicators for congestive heart failure care. | |
| | |
MedLine Citation:
|
PMID: 12704479 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Quality indicators are measurement tools for assessing the structure, processes and outcomes of care. Although quality indicators have been developed in other countries, Canadian cardiovascular disease indicators do not exist. OBJECTIVE: To develop quality indicators for measuring and improving congestive heart failure (CHF) care in Canada. METHODS: An 11-member multidisciplinary national expert panel was selected from nominees from national medical organizations. Potential quality indicators were identified by a detailed search of published guidelines, randomized trials and outcomes studies. A two-step modified Delphi process was employed with an initial screening round of indicator ratings, followed by a national quality indicator panel meeting, where definitions of the indicators were developed using consensus methods. Indicators were designed to be measurable, using retrospective chart review and linking existing administrative databases. RESULTS: The case definition criterion was developed based on a discharge diagnosis of CHF (International Classification of Diseases, 9th revision [ICD-9] code 428.x), with diagnostic confirmation using clinical criteria. In total, 29 indicators and five test indicators were recommended. Process indicators included prescription for angiotensin-converting enzyme inhibitors, beta-blockers or warfarin (for atrial fibrillation) at hospital discharge. Nonpharmacological in hospital process indicators included evaluation of left ventricular function, weight measurement and selected patient education counselling instructions. Process indicators in the ambulatory setting included prescription and adherence to drug therapies and physician follow-up. Outcome indicators included mortality, readmissions and emergency visits. CONCLUSIONS: A set of Canadian quality indicators for CHF care encompassing organizational attributes, pharmacotherapy, investigations, counselling, continuity of care and disease outcomes has been developed. These quality indicators will serve as a foundation for future studies evaluating the quality of CHF care in Canada. |
| | |
Authors:
|
Douglas S Lee; Chau Tran; Virginia Flintoft; F Curry Grant; Peter P Liu; Jack V Tu; |
Related Documents
:
|
10142019 - Cooperation and consensus in the outcomes movement. 18089769 - Review: how do hospital organizational structure and processes affect quality of care?:... 15715179 - Rapid-cycle improvement in quality of care for patients hospitalized with acute myocard... 1792039 - Development of an acute pain service monitoring and evaluation system. 20801869 - Quality initiatives: department scorecard: a tool to help drive imaging care delivery p... 3089899 - Effects of proprietary management in general hospital psychiatric units. 18642019 - Cost-effectiveness sequential modeling of ranibizumab versus usual care in age-related ... 21092429 - Rural patients' experiences accessing surgery in british columbia. 19959789 - Careful climbing in the miocene: the forelimbs of ardipithecus ramidus and humans are p... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The Canadian journal of cardiology Volume: 19 ISSN: 0828-282X ISO Abbreviation: Can J Cardiol Publication Date: 2003 Mar |
Date Detail:
|
Created Date: 2003-04-21 Completed Date: 2003-05-01 Revised Date: 2008-04-09 |
Medline Journal Info:
|
Nlm Unique ID: 8510280 Medline TA: Can J Cardiol Country: Canada |
Other Details:
|
Languages: eng Pagination: 357-64 Citation Subset: IM |
Affiliation:
|
University of Toronto, Toronto, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use Ambulatory Care / standards Angiotensin-Converting Enzyme Inhibitors / therapeutic use Benchmarking Canada Delphi Technique Health Services Research Heart Failure / prevention & control* Hospitalization Humans International Classification of Diseases National Health Programs / standards Outcome and Process Assessment (Health Care) / classification* Patient Education as Topic Physician's Practice Patterns Quality Indicators, Health Care* Ventricular Function, Left Warfarin / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 81-81-2/Warfarin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Elastofibromatous polyp of the sigmoid colon--a case report and review of gastrointestinal elastofib...
Next Document: Improving the continuity of care following discharge of patients hospitalized with heart failure: is...